藥品參考
Somatrogon
Somatrogon is a medicine in the class endocrine. It is used for growth failure.
- 藥物類別: Endocrine
- 用途: growth failure
最後更新 來源: US FDA label
僅供醫療專業人員參考。本頁為簡要摘要，並非醫療建議，亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。
本頁的臨床內容僅提供英文版。
重點資訊
- 藥物類別
- Endocrine
- ATC 代碼
- H01AC08
- 常見劑型
- 注射劑
- 常見規格
- 24 mg
- 已知交互作用
- 98 (中度: 57 · 輕微: 41)
- 商品名
- 3
- 國家與市場
- 3
用途
作用方式
Somatrogon-ghla binds the GH receptor and activates the STAT5b signaling pathway, raising serum IGF-1. GH and IGF-1 stimulate metabolic changes, linear growth and growth velocity in pediatric patients with GHD.
懷孕與哺乳
- 懷孕
- Unknown No human data for this long-acting growth hormone; no harm in rats at up to 45 times human exposure. UK label: not recommended in pregnancy or without contraception. Growth hormone is usually stopped once pregnancy is confirmed.
- 哺乳
- Unknown No milk data. UK label: decide whether to stop breastfeeding or the drug; US: weigh benefits. LactMed: poorly absorbed orally and unlikely to reach the infant, but with no experience an alternative may be preferred with a newborn or preterm infant.
已通報的副作用
- Injection site reactions
- Nasopharyngitis
- Headache
- Pyrexia
- Anemia
- Cough
禁忌症
- Acute critical illness after open heart surgery, abdominal surgery or multiple accidental trauma, or acute respiratory failure
- Hypersensitivity to somatrogon-ghla or any excipients
- Closed epiphyses
哪些人需要特別留意
- Severe hypersensitivity reactions including anaphylaxis and angioedema may occur; seek prompt medical attention.
- Increased risk of neoplasms; monitor patients with preexisting tumors and childhood cancer survivors; discontinue if malignancy recurs.
- May decrease insulin sensitivity; monitor glucose periodically; antidiabetic doses may need adjustment.
請告知藥師或醫師您是否懷孕或哺乳、是否患有腎臟或肝臟疾病、是否有過敏，以及您正在使用的所有其他藥物或保健品。
重要交互作用 (98)
- Alogliptin + Somatrogon Moderate
- Alogliptin-metformin + Somatrogon Moderate
- Alogliptin-pioglitazone + Somatrogon Moderate
- Canagliflozin-metformin + Somatrogon Moderate
- Chlorpropamide + Somatrogon Moderate
- Cyclosporin + Somatrogon Moderate
- Dapagliflozin-metformin + Somatrogon Moderate
- Deflazacort + Somatrogon Moderate
- Desogestrel-ethinyl estradiol + Somatrogon Moderate
- Dexamethasone + Somatrogon Moderate
同類別的其他藥品
常見問題
What is Somatrogon used for?
Somatrogon is a medicine in the class endocrine. It is used for Growth failure, Growth hormone deficiency.
What side effects have been reported with Somatrogon?
Injection site reactions, Nasopharyngitis, Headache, Pyrexia, Anemia, Cough.
Can Somatrogon be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. No human data for this long-acting growth hormone; no harm in rats at up to 45 times human exposure. UK label: not recommended in pregnancy or without contraception. Growth hormone is usually stopped once pregnancy is confirmed. Breastfeeding: Unknown. No milk data. UK label: decide whether to stop breastfeeding or the drug; US: weigh benefits. LactMed: poorly absorbed orally and unlikely to reach the infant, but with no experience an alternative may be preferred with a newborn or preterm infant.
What does Somatrogon interact with?
MediHelp lists 98 known interactions for Somatrogon. Moderate: 57 · Minor: 41. The most serious include Alogliptin, Alogliptin-metformin, Alogliptin-pioglitazone.
在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查
在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用，並使用劑量工具。
